147 related articles for article (PubMed ID: 37598854)
21. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
[TBL] [Abstract][Full Text] [Related]
22. Membranous Nephropathy with Lambda Light Chain Restriction: A Rare Form with Serum Negative and Tissue Positive PLA2R Ab.
Isiktas Sayilar E; Kiremitci S; Ergun I; Ensari A
Nephron; 2022; 146(4):377-380. PubMed ID: 34937026
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic role of renal biopsy in PLA
Wiech T; Stahl RAK; Hoxha E
Mod Pathol; 2019 Sep; 32(9):1320-1328. PubMed ID: 30962506
[TBL] [Abstract][Full Text] [Related]
24. Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy.
Le Quintrec M; Teisseyre M; Bec N; Delmont E; Szwarc I; Perrochia H; Machet MC; Chauvin A; Mavroudakis N; Taieb G; Lanfranco L; Rigothier C; José B; Concetta C; Geneste C; Pernin V; Larroque C; Devaux J; Beyze A
Kidney Int; 2021 Dec; 100(6):1240-1249. PubMed ID: 34600965
[TBL] [Abstract][Full Text] [Related]
25. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
26. Membranous nephropathy: new pathogenic mechanisms and their clinical implications.
Hoxha E; Reinhard L; Stahl RAK
Nat Rev Nephrol; 2022 Jul; 18(7):466-478. PubMed ID: 35484394
[TBL] [Abstract][Full Text] [Related]
27. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.
Ramachandran R; Kumar V; Kumar A; Yadav AK; Nada R; Kumar H; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Nephrol Dial Transplant; 2016 Sep; 31(9):1486-93. PubMed ID: 26673907
[TBL] [Abstract][Full Text] [Related]
28. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
[TBL] [Abstract][Full Text] [Related]
29. Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy.
Reinhard L; Machalitza M; Wiech T; Gröne HJ; Lassé M; Rinschen MM; Ferru N; Bräsen JH; Drömann F; Rob PM; Sethi S; Hoxha E; Stahl RAK
J Am Soc Nephrol; 2022 Oct; 33(10):1823-1831. PubMed ID: 35985817
[TBL] [Abstract][Full Text] [Related]
30. Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.
Seitz-Polski B; Dolla G; Payré C; Girard CA; Polidori J; Zorzi K; Birgy-Barelli E; Jullien P; Courivaud C; Krummel T; Benzaken S; Bernard G; Burtey S; Mariat C; Esnault VL; Lambeau G
J Am Soc Nephrol; 2016 May; 27(5):1517-33. PubMed ID: 26567246
[TBL] [Abstract][Full Text] [Related]
31. Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
Mahmud M; Pinnschmidt HO; Reinhard L; Harendza S; Wiech T; Stahl RAK; Hoxha E
PLoS One; 2019; 14(9):e0221293. PubMed ID: 31498806
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of PLA
Schmidt T; Schulze M; Harendza S; Hoxha E
J Nephrol; 2021 Apr; 34(2):603-606. PubMed ID: 33026632
[TBL] [Abstract][Full Text] [Related]
34. Genetic determinants of the development and course of membranous nephropathy.
Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE
Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913
[TBL] [Abstract][Full Text] [Related]
35. [Update membranous nephropathy].
Hoxha E; Huber TB
Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
[TBL] [Abstract][Full Text] [Related]
36. Experimental models for elderly patients with membranous nephropathy: Application and advancements.
Tang X; Dai H; Hu Y; Liu W; Zhao Q; Jiang H; Feng Z; Zhang N; Rui H; Liu B
Exp Gerontol; 2024 Jan; 185():112341. PubMed ID: 38042380
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
38. [Detection of PLA2R1 in renal biopsy specimens of patients with idiopathic membranous nephropathy].
Zhu SS; Zhou SL; Zhou CM; Li YQ; Zou HQ
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):526-9. PubMed ID: 25907937
[TBL] [Abstract][Full Text] [Related]
39. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.
Coenen MJ; Hofstra JM; Debiec H; Stanescu HC; Medlar AJ; Stengel B; Boland-Augé A; Groothuismink JM; Bockenhauer D; Powis SH; Mathieson PW; Brenchley PE; Kleta R; Wetzels JF; Ronco P
J Am Soc Nephrol; 2013 Mar; 24(4):677-83. PubMed ID: 23431073
[TBL] [Abstract][Full Text] [Related]
40. APC ameliorates idiopathic membranous nephropathy by affecting podocyte apoptosis through the ERK1/2/YB-1/PLA2R1 axis.
Ke B; Shen W; Liao Y; Hu J; Tu W; Fang X
Mol Cell Biochem; 2023 Sep; 478(9):1999-2011. PubMed ID: 36588134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
